Joerg Berghausen

Title: Joerg Berghausen: Innovator in Pharmaceutical Chemistry

Introduction

Joerg Berghausen is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for pain management. With a total of 2 patents, his work has the potential to impact the treatment of various disorders.

Latest Patents

Berghausen's latest patents include innovative formulations and processes. One of his patents focuses on HCI polymorphs of 3-((2-(dimethylamino)methyl(cyclohex-1-yl)) phenol. This patent describes a crystalline salt of 3-[2-(dimethylamino)methyl(cyclohex-1-yl)]phenol and hydrogen chloride, preferably in a 1:1 composition. It includes various crystalline forms of this salt, processes for preparing these forms, and pharmaceutical compositions containing them. The use of this salt as a pharmacologically active agent in treating or inhibiting pain or other disorders is also highlighted.

Another patent by Berghausen involves the salt of dimethylaminomethyl-phenyl-cyclohexane and its crystalline forms. This patent presents novel 3-[2-(dimethylamino)methyl-(cyclohex-1-yl)]-phenol maleate compounds and processes for their preparation. It also discusses pharmaceutical compositions that include these compounds and methods for treating or alleviating pain with them.

Career Highlights

Joerg Berghausen is currently associated with Gruenenthal GmbH, a company known for its focus on pain management and innovative pharmaceutical solutions. His work at Gruenenthal has allowed him to explore and develop new therapeutic options that can significantly improve patient outcomes.

Collaborations

Throughout his career, Berghausen has collaborated with esteemed colleagues, including Michael Gruss and Wolfgang Hell. These collaborations have fostered an environment of innovation and have contributed to the advancement of pharmaceutical research.

Conclusion

Joerg Berghausen is a prominent figure in pharmaceutical chemistry, with a focus on developing innovative compounds for pain management. His contributions through patents and collaborations highlight his commitment to improving healthcare solutions.